NDC 50090-6089-01 - Levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-6089
- Requested NDC
- 50090-6089-01
- Package NDCs from labels
- 50090-6089-0, 50090-6089-1, 50090-6089-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2025-07-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine sodium - A-S Medication Solutions | A-S Medication Solutions | 2025-07-15 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-6089-0 | Levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 5 | |
| 50090-6089-1 | Levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-6089 | LEVOTHYROXINE SODIUM TABLET [A-S MEDICATION SOLUTIONS] | 3 | Current NDC, Legacy NDC, 2 package rows | 20230602_70d84fe0-afc4-4ef2-b4d8-f156abac3d1f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-6089-0 | EA - Each | 50090-6089 | 1b7b2683-840d-46d0-917e-a7d77279de70 | 1 | 2022-10-06 |
| 50090-6089-1 | EA - Each | 50090-6089 | bbb03dd6-2ec1-454d-b7e9-edf6bd5c9c2f | 1 | 2022-10-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Magnesium Oxide | MAGNESIUM OXIDE | Belleview Biosciences | 31bc45c7-ba92-bad0-e063-6394a90a9af8 | 2025-04-01 | Warnings | 3A3U0GI71G |
| Strovite One Caplets | VITAMIN A, CALCIUM PANTOTHENATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL SUCCINATE, D-, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, BIOTIN, CYANOCOBALAMIN, SELENIUM, MAGNESIUM OXIDE, ZINC OXIDE, CUPRIC SULFATE, MANGANESE, CHROMIUM, .ALPHA.-LIPOIC ACID, AND LUTEIN | Exeltis USA, Inc. | b9b71fa4-89c7-4f5b-8174-950649434ba5 | 2025-03-20 | Warnings, Adverse reactions | 3A3U0GI71G |
| Vitafol Fe Plus | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, BETA CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM | Exeltis USA, Inc. | 3927b074-d72a-4d8c-9f7e-15c42a830945 | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | 3A3U0GI71G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 30ccec8b-3f95-61c7-e063-6394a90a05a0 | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Lupin Pharmaceuticals, Inc. | 18717e58-89fb-4e2f-93b6-d6ac3e988d37 | 2025-03-19 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 892255 966224 966249 966220 966225 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Fresenius Kabi USA, LLC | 08f4b1f8-6807-47e7-bef8-8d1972aa0557 | 2025-03-17 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Vitafol Ultra | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, .BETA.-CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM | Exeltis USA, Inc. | 40fa2c3a-f41f-434c-91de-5150a18d3e4b | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | 3A3U0GI71G |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | f0a63075-631d-43bf-9d8e-df79faf0a278 | 2025-02-01 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 2cf48978-d996-f5ba-e063-6294a90a8824 | 2025-01-30 | Boxed warning, Warnings, Adverse reactions | 892251 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 702016f6-8507-471f-b833-3a582aef5d2e | 2025-01-28 | Boxed warning, Warnings, Adverse reactions | 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | RedPharm Drug, Inc | fcb196a2-31a6-437a-e053-6294a90a98ad | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966270 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Redpharm drug | fa1bbb6e-ed15-07c9-e053-6294a90aa4a0 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966222 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Redpharm drug | fa2aebcd-3cd8-5128-e053-6294a90ac612 | 2025-01-23 | Boxed warning, Warnings, Adverse reactions | ANDA212399 892246 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Direct Rx | dd032289-acee-49fc-e053-2a95a90a5999 | 2025-01-22 | Warnings, Adverse reactions | ANDA212399 892251 9J765S329G |
| levothyroxine sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | fc803107-aaa2-4753-ab97-7b4ed5cf4be5 | 2025-01-21 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | ddec2148-f97e-4a79-9943-4bef2386a7f2 | 2025-01-21 | Boxed warning, Warnings, Adverse reactions | 966220 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Preferred Pharmaceuticals Inc. | 7ade3f9e-e3d2-401b-a6b7-aa4c9d1c9861 | 2025-01-20 | Boxed warning, Warnings, Adverse reactions | 966222 892246 966249 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Direct_rx | 2b4bbe49-4bd0-ba16-e063-6394a90acefc | 2025-01-09 | Warnings, Adverse reactions | ANDA212399 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Direct_Rx | 2b361866-e981-567c-e063-6294a90a5a5c | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | ANDA212399 966248 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.